Skip to main content
JINLING PHARMACEUTICAL CO.,LTD logo

JINLING PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 000919 ISIN · CNE0000010W5 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,771 across all filing types
Latest filing 2019-06-21 AGM Information
Country CN China
Listing Shenzhen Stock Exchange 000919

About JINLING PHARMACEUTICAL CO.,LTD

https://www.jlyy1999.com

Jinling Pharmaceutical Co., Ltd. specializes in the research, development, manufacture, and sale of pharmaceutical products, with a focus on chemical drugs and traditional Chinese medicine preparations. The company’s product portfolio primarily targets cardiovascular and cerebrovascular diseases, anti-tumor treatments, and digestive system health. A prominent product in its lineup is the Mailuoning Injection, utilized for treating various vascular conditions. In addition to its manufacturing operations, the company is involved in the management and operation of medical institutions, integrating clinical services with pharmaceutical production. Its business model emphasizes the synergy between drug development and healthcare service delivery to provide integrated medical solutions.

Recent filings

Filing Released Lang Actions
关于召开2018年年度股东大会的提示性公告
AGM Information Classification · 95% confidence The document is a detailed announcement regarding the convening of the 2018 Annual General Meeting (AGM) of Jinling Pharmaceutical Co., Ltd. It includes information about the meeting date, voting procedures, agenda items including the 2018 annual reports and financial statements, and proxy voting instructions. The document does not contain the actual annual report or financial statements but rather serves as a notice and instructions for shareholders to participate in the AGM. The presence of agenda items such as the 2018 annual report and financial statements indicates it is related to the AGM. The document length is about 5,526 characters, which is consistent with a detailed AGM notice rather than a full annual report. Therefore, this document fits the category of AGM Information (AGM-R).
2019-06-21 Chinese
独立董事关于公司第七届董事会第十六次会议审议的有关议案及相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from independent directors regarding the appointment of a senior management member at a board meeting. It references compliance with company law and securities regulations, and discusses the qualifications and approval of a vice president appointment. There is no financial data, no report publication, no voting results, and no earnings or audit information. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2019-06-06 Chinese
关于召开2018年年度股东大会的通知
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2018 Annual General Meeting (AGM) of Jinling Pharmaceutical Co., Ltd. It includes information about the meeting date, voting procedures, agenda items including the 2018 annual reports and financial statements, and proxy voting instructions. The document does not contain the actual annual report or financial statements but rather serves as a formal notification to shareholders about the AGM and the matters to be discussed and voted upon. This matches the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, including notices and agendas. The document length and content confirm it is not a brief announcement or a full annual report but a comprehensive AGM notice.
2019-06-06 Chinese
第七届董事会第十六次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement from the board of directors of Jinling Pharmaceutical Co., Ltd. It details the resolutions passed at the 16th meeting of the 7th Board of Directors, including the appointment of a new vice president and the renaming of a company department. It also mentions the proposal to convene the 2018 Annual General Meeting. The document includes voting results and references to related notices published elsewhere. The content focuses on board decisions and management changes rather than financial results or reports. The document length is short (1683 characters) and is clearly a meeting resolution announcement. Therefore, it fits the category of Board/Management Information (MANG).
2019-06-06 Chinese
监事会关于公司监事辞职的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the resignation of a company supervisor (监事) from the supervisory board of Jinling Pharmaceutical Co., Ltd. It details the resignation date, the legal compliance with the minimum number of supervisors, and the stock holdings of the resigning supervisor. There is no financial data, no report attached or referenced as being published, and no mention of financial results or management changes at the board or senior management level. This fits the category of Board/Management Information (MANG), as it concerns changes in company supervisory board personnel.
2019-06-03 Chinese
第七届董事会第十五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement from the board of directors of Jinling Pharmaceutical Co., Ltd. It details the resolutions passed at the 15th meeting of the 7th Board of Directors, including approval of a change in accounting policy, approval of the company's 2019 first quarter report, and appointment of a new vice president. The document includes voting results and references to where the full quarterly report can be found, but does not contain the full financial statements or detailed financial analysis itself. The document is relatively short (1827 characters) and serves as a meeting resolution announcement rather than the full quarterly report. Therefore, it is best classified as a Board/Management Information (MANG) filing, as it announces board decisions and management changes.
2019-04-29 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.